Sign In
CLOV.US
id: 686

Clover Health Investments (CLOV) $22M Investor Settlement

The process of distributing settlement funds to claimants has started.
$22,000,000
Cash Settlement
M.D. Tennessee
Court
3:21-cv-00096
Case number
10/06/2020
Class period Start
02/03/2021
Class period End
10/09/2023
Claim deadline
Clover Health Investments settles $22 million with Investors to end claims over concealing DOJ investigation $CLOV faced in the lead-up to its go-public merger with a SPAC.
Case Status
Disbursement
Alleged Offence
Misleading Statements
Financial Misrepresentation
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.22
Filing date
02/05/2021
Plaintiffs
Firas Jabri, Jean-Nicolas Tremblay
Attorneys
Bramlett Law Offices (Nashville, TN), Pomerantz LLP (New York, NY), The Schall Law Firm (Los Angeles, CA)
Defendants
Vivek Garipalli, Andrew Toy, Joseph Wagner, Chamath Palihapitiya
Judge
Hon. Aleta A. Trauger
Administrator
JND Legal Administration
Settlement agreement date
2023-05-25
Court hearing date
10/02/2023
Exclusion deadline
09/11/2023
Objection deadline
09/11/2023
Hearing deadline
09/11/2023
Trades matching type
FIFO

Clover Health Investments Corp

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eli...

    Ticker
    CLOV.US
    ISIN
    US18914F1030
    CIK
    0001144514
    Sector
    Healthcare
    Industry
    Healthcare Plans
    Country
    USA
    Address
    1209 Orange Street, Wilmington, DE, United States, 19801